Уткин Дмитрий Олегович
Sechenov University · 56 works · 201 citations · h-index 7
Top works
- Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis
- Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer
- Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma
- Hypermethylation of Genes in New Long Noncoding RNA in Ovarian Tumors and Metastases: A Dual Effect
- Hypermethylated Genes of MicroRNA in Ovarian Carcinoma: Metastasis Prediction Marker Systems
- Matrix metalloproteinases: structure, functions and genetic polymorphism
- Soluble forms of immune checkpoint receptor PD-1 and its ligand PD-L1 in plasma of patients with ovarian neoplasms
- CLINICAL SIGNIFICANCE OF METHYLATION OF A GROUP OF MIRNA GENES IN OVARIAN CANCER PATIENTS
- Prognostic role of the vWF/ADAMTS-13 axis in thrombosis risk stratification in gynecologic oncology patients
- Influence of female hormones on the P-glycoprotein functioning
- Identification of Novel Differentially Expressing Long Non-Coding RNAs with Oncogenic Potential
- Current approaches to the treatment of vulvovaginal atrophy in women with gynecological and breast cancer
- Recurrent thrombosis in malignant neoplasms: clinical significance of long-term anticoagulant prophylaxis
- MOLECULAR AND BIOLOGICAL ASPECTS OF ENDOMETRIAL CANCER: CURRENT STATE OF THE PROBLEM
- Hypermethylation of new long noncoding RNA genes in ovarian tumors and metastases: a dual effect
- Sentinel lymph node biopsy in endometrial cancer: current status (literature review)
- Comparative estimation of the effectiveness of the Khorana, Vienna CATS, and TiC-Onco scores and the vWF/ADAMTS13 ratio in identifying a high risk of thrombotic complications in patients with malignant neoplasms
- Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer – the SENTRY clinical trial
- THE CONTENT OF MATRIX METALLOPROTEINASE-7 IN BLOOD SERUM AND TUMOR IN PATIENTS WITH OVARIAN CANCER
- Novel miRNAs as Potential Regulators of PD-1/PD-L1 Immune Checkpoint, and Prognostic Value of MIR9-1 and MIR124-2 Methylation in Ovarian Cancer